DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
SAMROTAMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Histiocytoma, Malignant Fibrous
Unknown
SAMROTAMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
SY5HF6N5MB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XANTHOHUMOL
1
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
XANTHOHUMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
T4467YT1NT
Molecule Type:
Small molecule
Molecular Formula:
C21H22O5
Molecular Weight:
354.4
AlogP:
4.22
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
COCAETHYLENE
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
COCAETHYLENE
×
Maximum Phase:
1
First Approval:
None
UNII:
FJO3071W5Y
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO4
Molecular Weight:
317.39
AlogP:
2.26
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
AMG553
1
Cell
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 binding agent
AMG553
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RINTODESTRANT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Ductal
Unknown
RINTODESTRANT
×
Maximum Phase:
1
First Approval:
None
UNII:
W3Y784Y0ES
Molecule Type:
Small molecule
Molecular Formula:
C26H19FO5S
Molecular Weight:
462.5
AlogP:
6.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SGN-CD123A
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
SGN-CD123A
×
Maximum Phase:
1
First Approval:
None
UNII:
89ATB9I3D2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-42396302
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-42396302
×
Maximum Phase:
1
First Approval:
None
UNII:
P5M4972608
Molecule Type:
Small molecule
Molecular Formula:
C19H23N5O2
Molecular Weight:
353.43
AlogP:
2.13
PSA:
64.78
HBD:
0.0
HBA:
#RotB:
5.0
Source:
AMY-101
1
Protein
Investigational
Unknown
Unknown
Gingivitis
Complement C3 inhibitor
AMY-101
×
Maximum Phase:
1
First Approval:
None
UNII:
4Z4DFR9BX7
Molecule Type:
Protein
Molecular Formula:
C83H117N23O18S2
Molecular Weight:
1789.13
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
IMC-1C11
1
Antibody
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor 2 inhibitor
IMC-1C11
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEGLARINAD CHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Nicotinamide phosphoribosyltransferase inhibitor
TEGLARINAD CHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D6V5QYX9MZ
Molecule Type:
Small molecule
Molecular Formula:
C30H43Cl2N5O8
Molecular Weight:
672.61
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
AMG-820
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Pancreatic Neoplasms
Macrophage colony stimulating factor receptor inhibitor
AMG-820
×
Maximum Phase:
1
First Approval:
None
UNII:
SZ3778HS3S
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04455242
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder
Unknown
PF-04455242
×
Maximum Phase:
1
First Approval:
None
UNII:
Y3530Z78QD
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O2S
Molecular Weight:
372.53
AlogP:
3.88
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
5-METHYL-2'-FLUOROARAURACIL F-18
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-METHYL-2'-FLUOROARAURACIL F-18
×
Maximum Phase:
1
First Approval:
None
UNII:
J932A2CDQO
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN2O5
Molecular Weight:
259.22
AlogP:
-1.57
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
CAB
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CAB
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ETHANE DIMETHANE SULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Renal Cell; Colonic Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin
Unknown
ETHANE DIMETHANE SULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
EW8V7BJ66Q
Molecule Type:
Small molecule
Molecular Formula:
C4H10O6S2
Molecular Weight:
218.25
AlogP:
-1.06
PSA:
86.74
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TIDUTAMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
TIDUTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
88635FW2QX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KO-539
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
KO-539
×
Maximum Phase:
1
First Approval:
None
UNII:
4MOD1F4ENC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIAPENEM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
BIAPENEM
×
Maximum Phase:
1
First Approval:
None
UNII:
YR5U3L9ZH1
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O4S
Molecular Weight:
350.4
AlogP:
-1.89
PSA:
102.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PUQUITINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PUQUITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WFG29AB872
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-923295A
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-923295A
×
Maximum Phase:
1
First Approval:
None
UNII:
072702W9QD
Molecule Type:
Small molecule
Molecular Formula:
C32H38ClN5O4
Molecular Weight:
592.14
AlogP:
4.51
PSA:
108.2
HBD:
3.0
HBA:
#RotB:
12.0
Source:
GI HEPTAPEPTIDE
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
GI HEPTAPEPTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D33CAJ796A
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC-116
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
CYC-116
×
Maximum Phase:
1
First Approval:
None
UNII:
YAX4981K2D
Molecule Type:
Small molecule
Molecular Formula:
C18H20N6OS
Molecular Weight:
368.47
AlogP:
3.07
PSA:
89.19
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FARLETUZUMAB ECTERIBULIN
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
FARLETUZUMAB ECTERIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
97
98
99
100
101
102
103
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA